Number | Cited Articles |
1 |
Zhe Li, Jingyong Xu, Hongyuan Cui, Jinghai Song, Jian Chen, Junmin Wei. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus. Medicine 2020; 99(20): e20302 doi: 10.1097/MD.0000000000020302
|
2 |
Zhi-Jun Dai, Xing-Han Liu, Meng Wang, Yan Guo, Wenge Zhu, Xiao Li, Shuai Lin, Tian Tian, Kang Liu, Yi Zheng, Peng Xu, Tianbo Jin, Xiaopeng Li. IL-18 polymorphisms contribute to hepatitis B virus-related cirrhosis and hepatocellular carcinoma susceptibility in Chinese population: a case-control study. Oncotarget 2017; 8(46): 81350 doi: 10.18632/oncotarget.18531
|
3 |
Sreelakshmi Kotha, ShuetFong Neong, Keyur Patel. Serum biomarkers for diagnosis and monitoring viral hepatitis and hepatocellular carcinoma. Expert Review of Molecular Diagnostics 2018; 18(8): 713 doi: 10.1080/14737159.2018.1496020
|
4 |
Erwin Ho, Stijn Van Hees, Sofie Goethals, Elke Smits, Manon Huizing, Sven Francque, Benedicte De Winter, Peter Michielsen, Thomas Vanwolleghem. Biobanking for Viral Hepatitis Research. Frontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00183
|
5 |
M. Rajesh Kumar, A. Manikandan, A. Sivakumar, V. Violet Dhayabaran. An eco-friendly catalytic system for multicomponent, one-pot synthesis of novel spiro-chromeno indoline-triones and their anti-prostate cancer potentials evaluated via alkaline phosphatase inhibition mechanism. Bioorganic Chemistry 2018; 81: 44 doi: 10.1016/j.bioorg.2018.07.037
|
6 |
Tomoaki Yoh, Satoru Seo, Satoshi Ogiso, Koshiro Morino, Ken Fukumitsu, Takamichi Ishii, Yuji Nakamoto, Kojiro Taura. Quantitative assessment of microvascular invasion in hepatocellular carcinoma using preoperative serological and imaging markers. HPB 2020; doi: 10.1016/j.hpb.2020.10.024
|
7 |
Vijay Pandyarajan, Rajalakshmi Govalan, Ju Dong Yang. Risk Factors and Biomarkers for Chronic Hepatitis B Associated Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(2): 479 doi: 10.3390/ijms22020479
|
8 |
Hongsheng Guo, Peng Li, Liudan Su, Kun Wu, Kai Huang, Ruizhi Lai, Jing Xu, Dingbao Sun, Shuxian Li, Ziliang Deng, Yan Wang, Haina Guo, Zhangquan Chen, Sen Wang. Low expression of IL-37 protein is correlated with high Oct4 protein expression in hepatocellular carcinoma. Gene 2020; 737: 144445 doi: 10.1016/j.gene.2020.144445
|
9 |
Maria Angeles Aller, Natalia Arias, Javier Blanco-Rivero, Gloria Balfagón, Jaime Arias. Portal hypertension: The desperate search for the placenta. Current Research in Translational Medicine 2019; 67(2): 56 doi: 10.1016/j.retram.2018.09.001
|
10 |
Juqiang Han, Jiarui Li, Yun Qian, Wenpeng Liu, Jiguang Liang, Zhigang Huang, Shuai Wang, Caiyan Zhao. Identification of plasma miR-148a as a noninvasive biomarker for hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2019; 43(5): 585 doi: 10.1016/j.clinre.2018.12.008
|
11 |
S. Van Hees, S. Bourgeois, H. Van Vlierberghe, T. Sersté, S. Francque, P. Michielsen, D. Sprengers, H. Reynaert, J. Henrion, S. Negrin Dastis, J. Delwaide, L. Lasser, J. Decaestecker, H. Orlent, F. Janssens, G. Robaeys, I. Colle, P. Stärkel, C. Moreno, F. Nevens, T. Vanwolleghem. Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes. Alimentary Pharmacology & Therapeutics 2018; 47(8): 1170 doi: 10.1111/apt.14560
|
12 |
Tian Hu, Jincheng Li, Chuhong Zhang, Xiu lv, Sai Li, Sha He, Hanxing Yan, Yixi Tan, Mingsheng Lei, Meiling Wen, Jianhong Zuo. The potential value of microRNA-4463 in the prognosis evaluation in hepatocellular carcinoma. Genes & Diseases 2017; 4(2): 116 doi: 10.1016/j.gendis.2017.03.003
|
13 |
Angelo Fassio, Luca Idolazzi, Ombretta Viapiana, Camilla Benini, Elisabetta Vantaggiato, Francesco Bertoldo, Maurizio Rossini, Davide Gatti. In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls. Clinical Rheumatology 2017; 36(10): 2377 doi: 10.1007/s10067-017-3734-2
|
14 |
Anders Boyd, Léa Duchesne, Karine Lacombe. Research gaps in viral hepatitis. Journal of the International AIDS Society 2018; 21: e25054 doi: 10.1002/jia2.25054
|
15 |
Lavinia Alice Balaceanu. Biomarkers <i>vs</i> imaging in the early detection of hepatocellular carcinoma and prognosis. World Journal of Clinical Cases 2019; 7(12): 1367-1382 doi: 10.12998/wjcc.v7.i12.1367
|
16 |
Bao-Min Shi, Wen Lu, Kun Ji, Yu-Feng Wang, Shuai Xiao, Xiu-Yan Wang. Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology 2017; 23(20): 3713-3720 doi: 10.3748/wjg.v23.i20.3713
|
17 |
Xiulan Xue, Wei Liao, Yugang Xing. Comparison of clinical features and outcomes between HBV-related and non-B non-C hepatocellular carcinoma. Infectious Agents and Cancer 2020; 15(1) doi: 10.1186/s13027-020-0273-2
|
18 |
Carol Lee, Siu Tim Cheung. STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma. Cancers 2019; 11(11): 1646 doi: 10.3390/cancers11111646
|
19 |
Gian Paolo Caviglia, Davide Giuseppe Ribaldone, Maria Lorena Abate, Alessia Ciancio, Rinaldo Pellicano, Antonina Smedile, Giorgio Maria Saracco. Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis. Scandinavian Journal of Gastroenterology 2018; 53(6): 734 doi: 10.1080/00365521.2018.1459824
|